Sfoglia per Rivista  CANCER TREATMENT REVIEWS

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 1 a 20 di 23
Titolo Data di pubblicazione Autore(i) File
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies 2015 De Bari, Berardino; Filippi, Andrea Riccardo; Mazzola, Rosario; Bonomo, Pierluigi; Trovò, Marco; Livi, Lorenzo; Alongi, Filippo
Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature 2022 Lombardi P.; Rossini D.; Crespi V.; Germani M.M.; Bergamo F.; Pietrantonio F.; Santini D.; Allegrini G.; Daniel F.; Pagani F.; Antoniotti C.; Zaniboni A.; Conca V.; Latiano T.P.; Boccaccino A.; Passardi A.; Tamburini E.; Masi G.; Di Maio M.; Cremolini C.
Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer 2020 Pietrantonio, Filippo; Randon, Giovanni; Romagnoli, Dario; Di Donato, Samantha; Benelli, Matteo; de Braud, Filippo
Breast reconstruction and radiation therapy: An Italian expert Delphi consensus statements and critical review 2021 Meattini I.; Becherini C.; Bernini M.; Bonzano E.; Criscitiello C.; De Rose F.; De Santis M.C.; Fontana A.; Franco P.; Gentilini O.D.; Livi L.; Meduri B.; Parisi S.; Pasinetti N.; Prisco A.; Rocco N.
Cancer stem cells hypothesis and stem cells in head and neck cancers. 2012 G. Mannelli;O. Gallo
CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancer 2021 Migliaccio I.; Bonechi M.; McCartney A.; Guarducci C.; Benelli M.; Biganzoli L.; Di Leo A.; Malorni L.
Critical focus on mechanisms of resistance and toxicity of m-TOR inhibitors in pancreatic neuroendocrine tumors 2017 Antonuzzo, L; Del Re, M; Barucca, V; Spada, F; Meoni, G; Restante, G; Danesi, R; Di Costanzo, F; Fazio, N
De-escalation of axillary irradiation for early breast cancer – Has the time come? 2021 Senkus E.; Cardoso M.J.; Kaidar-Person O.; Lacko A.; Meattini I.; Poortmans P.
Dedifferentiated melanomas: Morpho-phenotypic profile, genetic reprogramming and clinical implications 2020 Massi D.; Mihic-Probst D.; Schadendorf D.; Dummer R.; Mandala M.
Hormone Receptor/Human Epidermal Growth Factor Receptor 2-positive breast cancer: Where we are now and where we are going 2016 Schettini, Francesco*; Buono, Giuseppe; Cardalesi, Cinzia; Desideri, Isacco; De Placido, Sabino; Del Mastro, Lucia
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 2022 Meattini, Icro; Livi, Lorenzo; Lorito, Nicla; Becherini, Carlotta; Bacci, Marina; Visani, Luca; Fozza, Alessandra; Belgioia, Liliana; Loi, Mauro; Mangoni, Monica; Lambertini, Matteo; Morandi, Andrea
Management of inflammatory breast cancer: Focus on radiotherapy with an evidence-based approach. 2013 Scotti, V; Desideri, I; Meattini, I; Cataldo, Vd; Cecchini, S; Petrucci, A; Franzese, C; Greto, D; Livi, L; Bonomo, P; Biti, G
Metabolomics in breast cancer: A decade in review 2018 McCartney, Amelia; Vignoli, Alessia; Biganzoli, Laura; Love, Richard; Tenori, Leonardo; Luchinat, Claudio; Di Leo, Angelo*
New strategies for targeting the hypoxic tumour microenvironment in breast cancer. 2013 C. Ward;S. P. Langdon;P. Mullen;A. L. Harris;D. J. Harrison;C. T. Supuran;I. H. Kunkler
Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability? 2022 Miglietta F.; Visani L.; Marini S.; Griguolo G.; Vernaci G.M.; Bottosso M.; Dieci M.V.; Meattini I.; Guarneri V.
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis 2023 Becherini, Carlotta; Visani, Luca; Caini, Saverio; Bhattacharya, Indrani S; Kirby, Anna M; Nader Marta, Gustavo; Morgan, Gilberto; Salvestrini, Viola; Coles, Charlotte E; Cortes, Javier; Curigliano, Giuseppe; de Azambuja, Evandro; Harbeck, Nadia; Isacke, Clare M; Kaidar-Person, Orit; Marangoni, Elisabetta; Offersen, Birgitte; Rugo, Hope S; Morandi, Andrea; Lambertini, Matteo; Poortmans, Philip; Livi, Lorenzo; Meattini, Icro
Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: Review and recommendations of the supportive task group of the Italian Association of Radiation Oncology 2012 Elvio G. Russi;Renzo Corvò;Anna Merlotti;Daniela Alterio;Pierfrancesco Franco;Stefano Pergolizzi;Vitaliana De Sanctis;Maria Grazia Ruo Redda;Umberto Ricardi;Fabiola Paiar;Pierluigi Bonomo;Marco C. Merlano;Valeria Zurlo;Fausto Chiesa;Giuseppe Sanguineti;Jacques Bernier
Targeting triple negative breast cancer: is p53 the answer? 2013 Turner N; Moretti E; Siclari O; Migliaccio I; Santarpia L; D'Incalci M; Piccolo S; Veronesi A; Zambelli A; Del Sal G; Di Leo A
The role of topoisomerase II alpha and HER-2 in predicting sensitivity to anthracyclines in breast cancer patients 2009 Oakman C; Moretti E; Galardi F; Santarpia L; Di Leo A
Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials 2022 Sobhani, Navid; Scaggiante, Bruna; Morris, Rachel; Chai, Dafei; Catalano, Martina; Tardiel-Cyril, Dana Rae; Neeli, Praveen; Roviello, Giandomenico; Mondani, Giuseppina; Li, Yong
Mostrati risultati da 1 a 20 di 23
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile